Skip to main content

RESMED INC

For the period ended Sep 30, 2024. Filed Oct 25, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2024 · Filed Oct 25, 2024

RMD$234.11-0.7%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Financial Information Financial Statements Condensed Consolidated Balance Sheets (Unaudited)

PART I – FINANCIAL INFORMATIONItem 1

Item 1. Financial Statements

Condensed Consolidated Balance Sheets (Unaudited)

(In US$ and in thousands, except share and per share data)

September 30,2024June 30,2024
Assets
Current assets:
Cash and cash equivalents$426,361$238,361
Accounts receivable, net of allowances of $23,600 and $21,132 at September 30, 2024 and June 30, 2024, respectively811,198837,275
Inventories (note 3)917,982822,250
Prepaid expenses and other current assets (note 3)485,584459,833
Total current assets2,641,1252,357,719
Non-current assets:
Property, plant and equipment, net (note 3)560,211548,025
Operating lease right-of-use assets157,068151,121
Goodwill (note 4)2,886,0172,842,055
Other intangible assets, net (note 3)478,613485,904
Deferred income taxes220,530203,569
Prepaid taxes and other non-current assets278,853284,001
Total non-current assets4,581,2924,514,675
Total assets$7,222,417$6,872,394
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable$249,278$237,728
Accrued expenses365,749377,678
Operating lease liabilities, current28,27825,278
Deferred revenue157,188152,554
Income taxes payable93,690107,517
Short-term debt, net (note 6)9,8969,900
Total current liabilities904,079910,655
Non-current liabilities:
Deferred revenue144,453137,343
Deferred income taxes83,52179,339
Operating lease liabilities, non-current144,490141,444
Other long-term liabilities83,27042,257
Long-term debt, net (note 6)667,578697,313
Total non-current liabilities1,123,3121,097,696
Total liabilities2,027,3912,008,351
Commitments and contingencies (note 8)
Stockholders’ equity:
Preferred stock, $0.01 par value, 2,000,000 shares authorized; none issued——
Common stock, $0.004 par value, 350,000,000 shares authorized; 189,662,212 issued and 146,776,149 outstanding at September 30, 2024 and 189,565,112 issued and 146,901,045 outstanding at June 30, 2024758588
Additional paid-in capital1,924,5841,896,604
Retained earnings5,225,1114,991,647
Treasury stock, at cost, 42,886,063 shares at September 30, 2024 and 42,664,067 shares at June 30, 2024(1,823,272)(1,773,267)
Accumulated other comprehensive loss(132,155)(251,529)
Total stockholders’ equity5,195,0264,864,043
Total liabilities and stockholders’ equity$7,222,417$6,872,394
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.